Adar Poonawalla, Chief Executive Officer of Serum Institute of India (SII), on Wednesday said one day after the launch of the first made-in-India Human Papillomavirus (HPV) “CERVAVAC” vaccine for the prevention of cervical cancer that the availability of vaccine will be limited this year, but will be increased next year. In New Delhi, Poonawalla informed Union Health Minister Mansukh Mandaviya of the HPV vaccine. After the meeting in an interview with ANI, the SII CEO said, “I had come to brief the Union Health minister about it. We’ll wait for the government program to roll out. Capacity is very small this year but we’ll build a large capacity to take care of the entire nation’s needs for next year.” View More